drugset / Trial / NCT07678385

Intraoperative Intravenous Lidocaine for Pain After Laparoscopic Appendectomy

NCT07678385 ↗

Phase 4 Completed 225 enrolled Hospital Universitario de Caracas
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This randomized, double-blind, placebo-controlled clinical trial evaluated whether intraoperative intravenous lidocaine infusion improves postoperative analgesia and recovery in patients undergoing laparoscopic appendectomy. The primary objective was to assess postoperative pain intensity and opioid consumption. Secondary outcomes included postoperative nausea and vomiting, time to bowel function recovery, length of hospital stay, plasma lidocaine concentrations, and adverse events.

Timeline

Start
2024-02-01
Primary completion
2025-01-01
Completion
2025-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified — Intravenous

Indications

No indication recorded.